ReShape Lifesciences, Inc. (RSLS) earnings

Quarterly and annual RSLS reports and results, each read against the price at its own news timestamp. Back to the RSLS overview →

10 measured RSLS earnings events.

DateHeadlineEvent5-minTo close
Form 10-Q ReShape Lifesciences For: Jun 30SEC filing · Form 10-Q——
Form 10-Q ReShape Lifesciences For: Mar 31SEC filing · Form 10-Q+3.36%-11.72%
Form NT 10-Q ReShape Lifesciences For: Mar 31SEC filing · Form NT-1.94%+5.02%
Form 10-K ReShape Lifesciences For: Dec 31SEC filing · Form 10-K+0.02%-5.80%
Form NT 10-K ReShape Lifesciences For: Dec 31SEC filing · Form NT-3.66%-30.16%
Form 10-Q ReShape Lifesciences For: Sep 30SEC filing · Form 10-Q+0.00%+6.94%
Form 10-Q ReShape Lifesciences For: Jun 30SEC filing · Form 10-Q-0.72%-2.81%
Form 10-Q ReShape Lifesciences For: Mar 31SEC filing · Form 10-Q+3.70%+5.05%
Form 10-K ReShape Lifesciences For: Dec 31SEC filing · Form 10-K+4.17%+0.48%
Form 10-Q ReShape Lifesciences For: Sep 30SEC filing · Form 10-Q-2.70%-2.70%
Get an email when RSLS moves on news →
Keep exploring

More RSLS: analyst actions → · SEC filings → · RSLS overview →

Other Healthcare names and their earnings

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.